Results 151 to 160 of about 84,630 (262)

Comparative Effectiveness of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors Versus Glucagon-Like Peptide-1 (GLP-1) Agonists on Cardiovascular and Renal Outcomes in Type 2 Diabetes: A Systematic Review and Network Meta-Analysis. [PDF]

Cureus
Alqurain AA, Salem M, Algarzai BA, Eljadi EM, Elsayed HS, Almuhanna A, Albuhayji DS, Salami M, Alzahrani J, Alsayyali J, Alqarni A, Alqahtani N, Alotaibi FT, Alyami GG.   +13 more
europepmc   +1 more source

Real-world data analysis of the risk of Fournier's gangrene in patients using sodium-glucose cotransporter 2 inhibitors (SGLT2i). [PDF]

Front Pharmacol
Hertel M, Jaoulak H, Heiland M, Nahles S, Preissner R, Preissner S.   +5 more
europepmc   +1 more source

Patient and Provider Characteristics Associated With Sodium–Glucose Cotransporter 2 Inhibitor Prescription in Patients With Diabetes and Proteinuric Chronic Kidney Disease

, 2020
Ian E. McCoy, Jialin Han, Maria E. Montez‐Rath, Glenn M. Chertow, Jinnie J. Rhee   +4 more
openalex   +2 more sources

Impact of an assessment form on promoting in-hospital initiation of sodium-glucose cotransporter-2 inhibitors in hospitalized patients with heart failure. [PDF]

Int J Cardiol Cardiovasc Risk Prev
Okamoto T, Matsumura K, Miyata H, Kimoto Y, Hamamura K, Kato K, Hakozaki S, Yagi E, Ueno M, Fujiwara K, Takegami M, Nakazawa G.   +11 more
europepmc   +1 more source

Sodium-Glucose Cotransporter 2 Inhibitors and Reduced Fibromyalgia Risk in Patients With Diabetes: A Target Trial Emulation Study. [PDF]

In Vivo
Jhang YS, Lu HY, Lin CY, Lee CY, Su YJ, Chang HC, Chen SJ, Gau SY.   +7 more
europepmc   +1 more source

Randomized, placebo‐controlled, double‐blind glycemic control trial of novel sodium‐dependent glucose cotransporter 2 inhibitor ipragliflozin in Japanese patients with type 2 diabetes mellitus [PDF]

, 2013
Atsunori Kashiwagi, Kenichi Kazuta, Satoshi Yoshida, Itsuro Nagase   +3 more
openalex   +1 more source

Blood Pressure Status Modulates the Therapeutic Response to Sodium-Glucose Cotransporter 2 Inhibitors in Diabetic Macular Edema: A Post Hoc Subgroup Analysis of the COMET Trial. [PDF]

J Diabetes
Ishibashi R, Koshizaka M, Takatsuna Y, Tatsumi T, Baba T, Yamamoto S, Yokote K.   +6 more
europepmc   +1 more source

Efficacy and safety of 11 sodium-glucose cotransporter-2 inhibitors at different dosages in type 2 diabetes mellitus patients inadequately controlled with metformin: a Bayesian network meta-analysis

Lei Xu, Yike Wu, Jiyifan Li, Yanan Ding, Junwei Chow, Longzhou Li, Haiyang Liu, Zihan Wang, Tingting Gong, Ting Li, Guo Ma   +10 more
openalex   +1 more source

Sodium–glucose cotransporter 2 inhibition: cardioprotection by treating diabetes—a translational viewpoint explaining its potential salutary effects [PDF]

, 2016
Anne E. de Leeuw, Rudolf A. de Boer
openalex   +1 more source

Sodium/Iodide Cotransporter [PDF]

, 2020
openaire   +1 more source